Literature DB >> 6299957

Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta.

A Dolei, M R Capobianchi, F Ameglio.   

Abstract

Human interferon-gamma was more effective than interferon-beta or -alpha in stimulating production of immunoassociated antigens; HLA-A, -B, and -C; and beta(2)-microglobulin in human M14 and Namalva cells. The comparison was made on the basis of antiviral units, and the stimulation could be abolished by treatment of the interferon-gamma preparation with pH 2 or anti-interferon-gamma serum.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6299957      PMCID： PMC264832          DOI： 10.1128/iai.40.1.172-176.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  25 in total

1.  Physiological regulation of antigen binding to T cells: role of a soluble macrophage factor and of interferon.

Authors:  P Lonai; L Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

2.  Common antigenic structures of HL-A antigens. IV. HL-A common portion fragment isolated from spent culture medium of human lymphoid cell lines.

Authors:  K Nakamuro; N Tanigaki; V P Kreiter; D Pressman
Journal:  Immunology       Date:  1974-12       Impact factor: 7.397

3.  Partial amino acid sequences of the heavy chains of human HLS histocompatibility antigens.

Authors:  E Appella; N Tanigaki; T Fairwell; D Pressman
Journal:  Biochem Biophys Res Commun       Date:  1976-07-12       Impact factor: 3.575

4.  Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon.

Authors:  J E Blalock; J A Georgiades; M P Langford; H M Johnson
Journal:  Cell Immunol       Date:  1980-02       Impact factor: 4.868

5.  Common antigenic structures of HL-A antigens. VI. Common antigenic determinants located on the 33,000 Dalton alloantigenic fragment portion of papain-solubilized HL-A molecules.

Authors:  K Nakamuro; N Tanigaki
Journal:  Immunology       Date:  1975-12       Impact factor: 7.397

6.  Enzymatic induction of interferon production by galactose oxidase treatment of human lymphoid cells.

Authors:  F Dianzani; T M Monahan; A Scupham; M Zucca
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

7.  Immune and virus-induced interferons may activate cells by different derepressional mechanisms.

Authors:  F Dianzani; M Zucca; A Scupham; J A Georgiades
Journal:  Nature       Date:  1980-01-24       Impact factor: 49.962

8.  Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon.

Authors:  I Heron; M Hokland; K Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

9.  H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;.

Authors:  R M Zinkernagel; P C Doherty
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

10.  Immunological dissection of human Ia molecules.

Authors:  R Tosi; N Tanigaki; D Centis; G B Ferrara; D Pressman
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307
View more
  19 in total

Review 1.  Autologous graft-versus-host disease.

Authors:  M J Kennedy; A D Hess
Journal:  Med Oncol       Date:  1995-09       Impact factor: 3.064

2.  Suppression of HLA class II expression on thyrocytes by interferon-alpha 1.

Authors:  V Guerin; I Todd; L J Hammond; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

Review 3.  IFN-induced modulation of histocompatibility antigens on human cells. Background, mechanisms and perspectives.

Authors:  M Hokland; P Basse; J Justesen; P Hokland
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

4.  Antiviral treatment of chronic hepatitis B virus infection.

Authors:  D M Novick; H C Thomas
Journal:  J R Soc Med       Date:  1984-12       Impact factor: 5.344

5.  Differential tissue distribution and ontogeny of DC-1 and HLA-DR antigens.

Authors:  P G Natali; O Segatto; S Ferrone; R Tosi; G Corte
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

6.  A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.

Authors:  J H Schiller; B Storer; D M Paulnock; R R Brown; S P Datta; P L Witt; E C Borden
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

7.  Differential effects of gamma interferon on expression of HLA class II molecules controlled by the DR and DC loci.

Authors:  F Ameglio; M R Capobianchi; A Dolei; R Tosi
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

8.  The effect of interferon treatment of targets on susceptibility to cytotoxic T-lymphocyte killing: augmentation of allogeneic killing and virus-specific killing relative to viral antigen expression.

Authors:  M J Blackman; A G Morris
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

9.  IFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread.

Authors:  M Zöller
Journal:  Clin Exp Metastasis       Date:  1988 Sep-Oct       Impact factor: 5.150

10.  Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells; correlation with the induction of other cytokines.

Authors:  F Ameglio; M R Capobianchi; C Castilletti; P Cordiali Fei; S Fais; E Trento; F Dianzani
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.